The tetracysteine sequence YRECCPGCCMWR fused to the N terminus of green fluorescent protein (GFP) self-aggregates upon biarsenical labeling in living cells or in vitro. Such dye-triggered aggregates form temperaturedependent morphologies and are dispersed by photobleaching. Fusion of the biarsenical aggregating GFP to the regulatory (R) or catalytic (C) subunit of PKA traps intact holoenzyme in compact fluorescent puncta upon biarsenical labeling. Contrary to the classical model of PKA activation, elevated cAMP does not allow RIa and Ca to diffuse far apart unless the pseudosubstrate inhibitor PKI or locally concentrated substrate is coexpressed. However, RIIa releases Ca upon elevated cAMP alone, dependent on autophosphorylation of the RIIa inhibitory domain. DAKAP1a overexpression induced R and C outer mitochondrial colocalization and showed similar regulation. Overall, effective separation of type I PKA is substrate dependent, whereas type II PKA dissociation relies on autophosphorylation.
INTRODUCTION
Protein kinase A (PKA) is essential for the regulation of diverse cellular processes, including ion channel conductance, metabolism, cell migration, and gene expression. Decades of research have elucidated many of the biological roles and unique properties of this prototypical kinase, yet recent evidence suggests that the classical mechanism of cAMP-induced dissociation and activation may require revision when explored in a cellular environment [1] .
PKA holoenzyme is present as two isoforms in cells, type I and type II, which are defined by the subtype of regulatory subunit, either RI or RII. Type II holoenzyme preferentially binds many A kinase-anchoring proteins (AKAPs) [2] , spatially localizing the holoenzyme to precise subcellular locations or near specific substrates. Whereas RII anchoring is generally static, anchoring of RI to AKAPs is more dynamic. Both RI and RII isoforms bind to C through specific interactions that include docking of an inhibitory peptide into the kinase active site [3] . Phosphorylation of serine at the phosphorylation site (P site) within the RII inhibitory domain decreases the binding affinity of type II PKA holoenzyme [4] and enhances dissociation. The corresponding position of RI is alanine. Although PKA has been thoroughly studied in vitro, it has been technically difficult to monitor the full dissociation of PKA in living cells.
The original evidence that cAMP induces PKA holoenzyme dissociation is based on decades-old chromatography experiments on dilute purified components [4] [5] [6] . We have previously shown in cells that cAMP can dissociate fluorescein-labeled C from rhodamine-labeled RI [7] or RII [8] as well as fluorescent protein fusions of C and RII [9] , as evidenced by decreases in fluorescent resonance energy transfer (FRET) and migration of C subunit into the nucleus, leaving R in the cytosol. However, random or site-specific chemical labeling of PKA subunits can alter the affinity of holoenzyme and dissociation dynamics (unpublished data), so such modified subunits may fail to reflect endogenous PKA dissociation, even while remaining usable for measuring cAMP. Interestingly, cAMPevoked decreases in FRET are generally larger with type II holoenzyme than type I [8, 9] , which were assumed to be a reflection of the difference in distance and orientation of the two fluorophores in the different PKA isoforms in unstimulated cells. Although dissociation is not required for a FRET change, if dissociation does occur, it reduces FRET all the way to zero, thus providing an additional and more powerful mechanism for FRET reduction than just a conformational readjustment. Recently, cAMPdependent conformational changes in type I and II PKA have been measured using bioluminescent resonance energy transfer (BRET), although this method sacrifices single-cell resolution [10] . In cells, cAMP and agonist analogs caused much smaller decreases in BRET in type I than in type II PKA. Time-resolved anisotropy of fluorescently labeled RIIa and Ca suggested that cAMP-bound holoenzyme is stable yet catalytically active [11] . Unfortunately, kinase activity and dissociation were not simultaneously measured, so the existence of an active intact holoenzyme is still controversial. Small-angle scattering has also verified a stable cAMP-bound form of type I PKA holoenzyme [12] . Despite the circumstantial evidence, intact cAMP-bound PKA holoenzyme has not been visualized in living cells.
During our efforts to optimize the fluorescence and affinity of the biarsenical tetracysteine system, we inadvertently discovered a specific tetracysteine-green fluorescent protein (GFP) that aggregated upon addition of the biarsenical dye ReAsH [13] . We now characterize the structural requirements for such aggregation in greater detail, then apply this system to study PKA dynamics in cells. By inducing colocalization of diffuse PKA holoenzyme, weak interactions between R and C subunits are trapped in highly visible puncta, providing a simple assay to study the mechanisms of C dissociation. The presence or absence of Ca in puncta reveals unique differences in the dissociation of type I and type II holoenzyme in living cells, leading to a new cellular understanding of PKA regulation. Furthermore, by DAKAP1a tethering, the effects of substrate concentration and Ca diffusion are correlated with PKA activity in live cells. This reversible system for induced protein colocalization and inactivation opens many opportunities to manipulate complex signaling pathways in living cells.
RESULTS
Biarsenical Dye-Triggered Aggregation of a Tetracysteine-GFP During mammalian cell-based selections for tetracysteine sequences with enhanced ReAsH brightness and affinity while fused to the N terminus of Emerald GFP [14] with an additional V163A mutation to improve folding, the tetracysteine sequence YRECCPGCCMWR was serendipitously isolated and found to undergo self-aggregation when labeled with ReAsH ( Figure 1A ; see Movie S1 in the Supplemental Data available with this article online). This tetracysteine-GFP fusion is hereafter referred to as BA-GFP for biarsenical aggregating GFP. By forming insoluble protein aggregates upon labeling, ReAsH-BA-GFP shields itself from high-dithiol washes. Additionally, due to the highly compact nature of the aggregates, FRET from GFP to ReAsH was very efficient, mediated by intermolecular FRET within coaggregated dye complexes. Because fluorescence-activated cell sorting (FACS) ignores subcellular localization, this particular sequence became highly enriched, representing the majority of clones by the final round of selection. Clearly the aggregates were not any more harmful than normal biarsenical labeling, as cells expressing high levels of the tag survived repeated rounds of ReAsH-induced aggregation and selection during several weeks in culture. BA-GFP clones eventually outcompeted other TC-GFP variants to dominate the final selection pool.
Aggregation occurs shortly after labeling with ReAsH or with the blue fluorescent analog CHoXAsH [15] , but not with the green fluorescent analog FlAsH [16] (Figure S1 ), whose protruding carboxyphenyl ring presumably blocks aggregation. To further understand the requirements for induced aggregation, the tetracysteine was separated from GFP and fused to the N terminus of b-actin and atubulin. Both cytoskeletal proteins expressed and localized appropriately in cells and labeled efficiently with ReAsH, but failed to aggregate ( Figure S2A ). When the complete tetracysteine-GFP tag was fused to the N terminus in a similar manner, aggregation of nonpolymerized b-actin or a-tubulin subunits occurred, but cells failed to retract and the cytoskeleton remained intact ( Figure S2B ), which could be due to the high levels of endogenous expression. Additionally, swapping the tetracysteine fusion to the C terminus of GFP prevented aggregation ( Figure S3A ). Fusion of small epitope tags, such as HA or Myc, N-terminal to the tetracysteine in BA-GFP did not disrupt aggregation, but the FLAG epitope or larger protein fusions were inhibitory ( Figures S3B and S3C ). Clearly, both N-terminal fusion to GFP and an unconstrained tetracysteine N terminus are important for inducible aggregation.
Replacement of Emerald GFP (F64L, S65T, S72A, N149K, M153T, V163A, I167T) with enhanced GFP (F64L, S65T) plus the folding mutation V163A ( Figures  S4A and S4B ) or mutation of the critical residue for chromophore formation, Y66A, drastically increased the critical concentration for aggregation from a few micromolar to near millimolar concentrations inside cells. Fusion to mGFP (F64L, S65T, S72A, N149K, M153T, V163A, I167T, plus the monomerizing mutation A206K) [17] had only a slight effect on the critical concentration ( Figures  S4A and S4B) , whereas fusions to either CFP or YFP lost all ability to aggregate ( Figure S3A ). Therefore, we chose to use BA-GFP including A206K (BA-mGFP) for further experiments. Purified BA-GFP protein also aggregated upon ReAsH or CHoXAsH labeling in vitro, demonstrating cellular factors are not required for aggregation. Salt removal or 1% SDS dissolved the in vitro precipitates, but the nonionic detergent NP-40 (1%) had no effect. Alanine scanning across six residues flanking the CCPGCC (Y 1 R 2 E 3 -CCPGCC-M 10 W 11 R 12 ) implied each residue except R 2 is important for aggregation in cells ( Figures S4C and S4D ). In summary, aggregation requires a tetracysteine-GFP fusion nearly identical to that originally isolated by FACS selection.
Temperature and Light Control of Aggregation
Depending on the biarsenical labeling temperature, different aggregate morphologies form in living cells. Room temperature labeling promotes the formation of punctate aggregates ( Figure 1B ) with limited diffusibility from the nucleation site. Alternatively, labeling at 37 C causes formation of fiber-like aggregates, which often coalesce into 1E ). Because of the high concentration of fluorophores present in aggregates, photo-generated free radicals presumably damage neighboring fluorophores, increasing the photobleaching rate of ReAsH by almost an order of magnitude ( Figure S5 ). Photo-induced dispersion of CHoXAsH aggregates requires far less light, as it is approximately two orders of magnitude less photo-stable than ReAsH. Photobleached tetracysteines fail to relabel with fresh biarsenical after dithiol washes, limiting reversible aggregation to one cycle.
To further understand the unique characteristics of this novel reversible aggregation tag, several BA-mGFP fusions were observed using correlated light and electron microscopy. Using the unique functionality of the biarsenical-tetracysteine system, ReAsH fluorescence was photo-oxidized to polymerize diaminobenzidine (DAB) for osmium staining and visualization by electron microscopy (EM) [18] . High-resolution electron micrographs of BA-mGFP labeled at room temperature show small tangles of small fibers radiating from the site of nucleation ( Figure 2A ). In contrast, BA-mGFP labeled at 37 C aggregates as ordered bundles, aligning the labeled protein into longer fibers ( Figure 2B ). Several PKA components were readily aggregated upon addition of either CHoXAsH or ReAsH into discrete highly fluorescent puncta. ReAsH aggregates of BA-mGFP-RIa or BAmGFP-Ca are present as round balls ( Figure 2C ), approximately the same size as mitochondria, whereas PKI aggregates as long, thick fibers similar to those seen when labeling at 37 C ( Figure 2D ). The nature of the aggregates are highly variable, but they clearly begin as single fibers of polymerized BA-mGFP that either intertwine or align to form various fiber-like structures.
PKA Holoenzyme Association Visualized by Coaggregation
BA-mGFP-RIa and BA-mGFP-Ca subunits are susceptible to biarsenical-induced aggregation, yet it was unclear whether intact PKA holoenzyme containing both RI and C was recruited to aggregates. Because the excitation peak of CHoXAsH is $100 nm blue-shifted from GFP, both BA-GFP and mCherry can be visualized without biarsenical excitation or bleaching. Coexpression of BA-mGFP-RIa and mCherry-Ca led to CHoXAsH-dependent coaggregation, demonstrating intact holoenzyme is indeed recruited. Unexpectedly, BA-mGFP-RIa and mCherry-Ca remained colocalized when prestimulated with forskolin, despite persistent cAMP elevation with the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) ( Figure 3A ;
Movie S2). This persistent association was not dependent on any specific order or size of fusion tag, as C-terminally tagged Ca-HA and Ca-mCherry behaved similarly. Likewise, BA-mGFP-Ca and mCherry-RIa also remained associated following stimulation ( Figure 3B ).
The PKA pseudosubstrate inhibitor PKI binds Ca about as strongly as cAMP-free RIa (K d = 0.15 nM). Both PKI and RIa are more than simply pseudosubstrate inhibitors, as each has high-affinity binding sites beyond the Ca substrate-binding domain. Coexpression of mCerulean-PKI showed little effect on RIa and Ca coaggregation in unstimulated, serum-starved cells ( Figure 3C ), but did prevent coaggregation in forskolin-stimulated cells ( Figure 3D ). PKI and RIa compete for a common Ca interaction site, and neither BA-mGFP-RIa and mCerulean-PKI or BA-mGFP-PKI and RIa coaggregate. Overexpression of the PKA model substrate mCerulean-kemptide (LRRASLG) (Figure 3E ) had no effect on RIa(cAMP) 2 and Ca coaggregation, but expression of mCerulean-PKI (A20S) (mutated from a pseudosubstrate to a substrate) did block most coaggregation ( Figure 3F ). Neither substrate was observed in aggregates. Therefore, substrate does not form a stable ternary complex with RI and C, but transiently competes with RI for access to the active site of free C, where it is immediately phosphorylated and released.
Regulatory Inhibitor Domain Regulates Ca Coaggregation
There are two general classes of functionally nonredundant PKA regulatory subunits in cells, RI and RII. To understand the dynamics of RII dissociation, we next tested BAmGFP-RIIa and BA-mGFP-RIIb in cells, but unfortunately both failed to efficiently aggregate with CHoXAsH. Aggregation may require sufficient linker flexibility, as RI has a flexible 11 residue linker but RII has only 1 or 2 residues before the dimerization domain. Although we could not directly aggregate RII, CHoXAsH aggregates of BAmGFP-Ca efficiently recruited mCherry-RIIa ( Figure 4A , upper). In contrast to RIa, mCherry-RIIa released from BA-mGFP-Ca when stimulated with forskolin alone (Figure 4A, lower) . This dissociation occurred exclusively in medium-to low-expressing cells, validating that cAMP raises the dissociation constant of phosphorylated RII holoenzyme to micromolar levels [4] . As was seen with type I PKA, BA-mGFP-Ca exchanged mCherry-RIIa for mCerulean-PKI only after cAMP stimulation. A fundamental difference between RI and RII is the sequence of the inhibitor domain that occupies the catalytic site of Ca [3] . The inhibitor domain of RI has an alanine at the P site, whereas RII contains a serine, which is autophosphorylated [19] . To determine the importance of the P site residue in RIIa, this site was mutated from Ser to Ala. This single mutation blocked cAMP-induced dissociation of mCherry-Ca from RIIa, even in the presence of mCerulean-PKI ( Figure 4B ). The analogous Ser-to-Glu mutation slightly affected holoenzyme formation, but upon stimulation, Ca dissociated in cells expressing even high levels of tagged type II holoenzyme ( Figure 4C ). In addition, the Glu substitution enhanced Ca accessibility for mCerulean-PKI. Phosphorylation of Ser-99 enhances displacement of the RII inhibitor domain, just as other PKA substrates are released after phosphorylation. To block P site phosphorylation by means other than mutation, we pretreated cells with the PKA ATP-binding site inhibitor H89 before raising cAMP. Unexpectedly, H89 not only allowed RIIa to dissociate from Ca but even promoted dissociation of RIIa S99A from Ca, suggesting additional destabilization of the complex.
Next, we reciprocally mutated the pseudosubstrate sequence of BA-mGFP-RIa to either Ser or Asp, which are known to support intact and cAMP-inducible holoenzyme in vitro [20] , albeit with reduced MgATP dependence and increased salt sensitivity. In cells, both mutants still formed holoenzyme, but unlike wild-type BA-mGFP-RIa, each mutation led to cAMP-induced separation in the absence of mCerulean-PKI ( Figures 5A and 5B ). Under basal conditions, mCerulean-PKI expression alone was sufficient to dissociate BA-mGFP-RIa A97D and in low-expressing BA-mGFP-RIa A97S cells, highlighting the importance of inhibitor displacement for activation. The aggregate density is also affected in BA-mGFP-RIa (A97D), which implies the mutation leads to further conformational changes that weaken aggregation. Altogether, the data presented exemplify a fundamental difference in RI and RII activation and demonstrate how P site phosphorylation of R subunits regulates their ability to release Ca.
Reversible Inhibition of Nuclear Signaling
In order to understand the functional consequences of intact cAMP-bound type I PKA, we assayed PKA activation in single living cells following forskolin and IBMX addition using the genetically encoded, nuclear-localized, ratiometric phosphorylation reporter AKAR2-NLS [21] . Coexpression of BA-mGFP-Ca and mCherry-RIa led to coaggregation and complete silencing of nuclear PKA activity upon labeling (Figure 6 ), as BA-mGFP-Ca aggregates contain both type I and type II PKA holoenzyme. Lowexpressing cells failed to completely inactivate nuclear PKA signaling, presumably because BA-mGFP-Ca levels must be sufficient to titrate endogenous Ca from native holoenzyme to BA-mGFP-Ca hybrid holoenzyme. PKA holoenzyme contains two C subunits and two R subunits, so BA-mGFP-Ca aggregates also contain endogenous C subunit recruited in trans. By photobleaching ReAsH BA-mGFP-Ca aggregates, nuclear activity is restored. These results demonstrate that PKA activity can be inducibly inhibited by biarsenical-dependent aggregation, and reversed by photo-induced reactivation without significant chromophore-assisted light inactivation [22] .
AKAP Colocalization Reveals SubstrateDependent Release AKAP-mediated targeting of PKA holoenzyme to subcellular locations is a key mechanism for spatially focusing PKA activity [2] . The dual isoform specific DAKAP1a localizes and concentrates both type I and type II holoenzyme to the outer mitochondrial membrane [23] . Overexpression of this AKAP leads to mitochondrial recruitment and colocalization of DAKAP1a-mCerulean, mGFP-RIa, and mCherry-Ca. Importantly, DAKAP1a localization could alter PKA dynamics by additional endogenous regulatory mechanisms, but because colocalization is not artificially induced, dissociation can be monitored dynamically without potential aggregation-induced artifacts. Following forskolin stimulation, mCherry-Ca remained colocalized to DAKAP1a and RIa at mitochondria ( Figure 7A ). As observed with aggregated cytosolic type I holoenzyme, complete dissociation from DAKAP1a-localized type I holoenzyme only occurred with both forskolin stimulation and coexpression of mCerulean-PKI. Also, similar to type II holoenzyme aggregates, mCherry-Ca released from DAKAP1a-localized mCerulean-RIIa following stimulation, dependent on low expression levels ( Figure 7B ). Intermediate dissociation was not observed in RIa-overexpressing cells, suggesting the amount of type II holoenzyme is overcome by RIa overexpression. Addition of the kemptide-based ratiometric fluorescent reporter AKAR2 had no effect on the separation of DAKAP1a-localized type I PKA holoenzyme following stimulation. Furthermore, cytosolic kinase activity is significantly reduced by DAKAP1a localization, correlating with the observed failure to dissociate ( Figure 7E ). DAKAP1a localization of type I PKA and expression of AKAR3 fused to the DAKAP targeting motif [24] colocalizes and concentrates both type I PKA holoenzyme and the reporter substrate. Forskolin and IBMX stimulation led to rapid dissociation of mCherry-Ca and a robust kinase response ( Figures 7D  and 7E ), demonstrating localized substrate is required for efficient release of Ca from AKAP-localized type I PKA holoenzyme in HeLa cells.
DISCUSSION
By selecting for dithiol-resistant ReAsH-labeled tetracysteine-GFP fusions, we identified a fluorescent tag capable of inducing self-aggregation when labeled with select biarsenical dyes. BA-GFP forms two distinct fiber morphologies dependent on the labeling temperature: puncta at room temperature or fibers at 37 C. Such temperature dependence is reminiscent of the yeast prion protein Sup35, which forms different heritable fiber morphologies dependent on growth temperature [25] . At 4 C, short, fragile, and more infectious prion strains develop, whereas at higher temperatures, longer, more stable, and less infectious prion strains form. We have also observed that certain protein fusions to BA-GFP favor the fiber-like morphology when labeled at room temperature, such as BAmGFP-b-lactamase and BA-mGFP-PKI. Due to the preferred Pro-Gly sequence internal to the cysteine pairs, we believe the optimal conformation for biarsenicalbound tetracysteines is a b hairpin, similar to the b sheets that define b-amyloid prions. The electron micrographs of BA-GFP show distinct filaments radiating from nucleation sites when labeled at room temperature, and those same fibers become highly ordered when formed at 37 C. More evidence is required to determine the ordering nature of BA-GFP aggregates, but it is intriguing that biarsenical labeling of a unique tetracysteine sequence can induce conformations in GFP that have similarities to protein conformational diseases.
Fusions to the FK506-binding protein (FKBP) and the rapamycin-binding protein (FRB) have found widespread use as a general method for chemically dimerizing Chemistry & Biology engineered proteins in cells upon addition of a divalent ligand [26] . Mutation of F36M in FKBP causes spontaneous homodimerization that reverses upon ligand addition [27] . Four tandem copies of the self-dimerizing F36M mutant of FKBP and one copy of GFP (>75 kDa total) spontaneously crosslink and form large, multiprotein aggregates that are dispersed upon addition of a specific ligand [27] , which has proven useful for sequestering proteins in the secretory pathway, such as insulin, for drug-dependent release [28] . Aggregation and dispersion depend on the addition and removal of ligand through incubations and washing steps. BA-GFP may not be as transferable to live animals, but it is smaller ($30 kDa), intrinsically fluorescent, captures weak interaction partners, and is rapidly reversible.
The sequence requirements for Ca dissociation from RIa have been visualized in living cells using a novel inducible aggregation tag. CHoXAsH-labeled BA-mGFP-RIa colocalizes in aggregates with mCherry-Ca-independent cAMP. Based on stop-flow kinetic measurements, the K d of cAMP-bound RIa (truncated to remove the dimerization domain) to Ca is 130 nM [29] , several-fold lower than the estimated cellular PKA concentration of 0.5 mM [1] . Dimers of the regulatory subunit will likely have a stronger affinity for Ca, which will further restrict its diffusion. Therefore, cAMP binding causes a conformational change that weakens type I PKA holoenzyme association but does not permit the majority of Ca to visually dissociate at endogenous concentrations [1] . Because BA-GFP requires several micromolar labeled protein to aggregate, we exclusively capture intact holoenzyme. Clearly, RIa(cAMP) 2 retains Ca nearby until sufficient substrate is present to promote Ca diffusion. The pseudosubstrate inhibitor PKI causes visible separation of RIa and Ca by trapping Ca and blocking reassociation. Although the binding and kinetic constants of full-length PKI have not been reported, the K i values of PKI , PKI [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] (A20pS), and kemptide are 5 nM, 94 mM, and 348 mM, respectively [30, 31] . The K m for kemptide and PKI [14] [15] [16] [17] [18] [19] [20] [21] [22] (A20S) are 4.7 mM and 0.11 mM, respectively [31] . Consequently, due to additional peripheral interactions, the PKI (A20S) is a more efficient substrate than kemptide. Kemptide has also been shown to directly compete with RIa(cAMP) 2 for binding Ca in vitro [32] . Altogether, by competing for free Ca, substrate concentration is critical for allowing Ca to diffuse away from RIa. Other mechanisms may also promote diffusion. For example, formation of type I holoenzyme is critically sensitive to ATP and Mg 2+ concentrations [33] , which has been suggested to regulate dissociation in cells. The N terminus of Ca also can bind AKIP1a, a novel A kinase-interacting protein that binds Ca and mediates nuclear translocation [34] . Additional posttranslation modifications, such as phosphorylation or myristoylation, could also enhance type I PKA dissociation. Overall, we believe sustained Ca dissociation from RIa is likely an orchestrated event that requires highly concentrated substrate and possibly other cell type-dependent mechanisms.
The inhibitor sequence of RIIa (RRVS) is a substrate for phosphorylation, whereas the consensus phosphorylation site of RIa (RRGA) contains an alanine at the P site. This fundamental difference changes type II PKA holoenzyme dissociation from substrate regulation to self-regulation by autophosphorylation. Phosphorylation of RIIa has been extensively studied and is known to weaken the affinity of cAMP-bound RIIa for Ca to approximately 6-10 mM in vitro [35, 36] . This value fits our observations, as we could only see complete dissociation in cells weakly expressing BA-mGFP-Ca and mCherry-RIIa, in which protein concentrations were probably low mM. Phosphorylation of RIIa is an essential step in Ca dissociation, exemplified by inhibition of dissociation by the Ser-to-Ala P site mutation, and the enhanced dissociation by the Ser-to-Glu P site mutation. Overall, colocalization of type II PKA holoenzyme with phosphatases should enhance reassociation by allowing the inhibitor domain to reassociate with Ca. Also, because AKAPs concentrate type II PKA holoenzyme to levels approaching the K d , they may localize activity by decreasing dissociation and diffusion.
AKAPs are known to localize PKA holoenzyme to specific subcellular environments to target specific substrates [2] . Using simple fluorescent protein fusions, we recapitulated our coaggregation results by colocalizing PKA holoenzyme to the surface of mitochondria with DAKAP1a. RIa failed to release Ca upon forskolin stimulation, whereas RIIa-bound Ca fully dissociated. Based on the K d of cAMP-bound type I holoenzyme in vitro, it is reasonable to assume that holoenzyme does reassociate when bound to cAMP. Therefore, AKAP tethering could focus kinase activity on a limited pool of substrates while sequestering type I PKA from leaving the local environment, especially after transient physiological stimulation. Interestingly, tethering PKA to the outside of mitochondria reduces the phosphorylation of diffuse substrates. Either AKAR2 does not have complete access to DAKAP1a-localized type I PKA, or substrate cannot efficiently compete against concentrated RIa. In vitro, increasing substrate concentration enhances type I PKA activity [32] . This enhancement is not allosteric, and can be interpreted as facilitating diffusion from RIa inhibition. It is paradoxical why Ca diffuses away from type II holoenzyme but not type I holoenzyme. RII is extensively targeted by numerous AKAPs to precise subcellular localizations, whereas RI is more dynamic and has fewer specific AKAPs. , mCherry-RIa, and DAKAP1a-mCerulean localize type I holoenzyme to mitochondria under basal conditions. DAKAP1a-mCerulean and mCherry-RIa colocalize to mitochondria with mGFP-Ca under all tested conditions (not shown). Forskolin/IBMX stimulation has no effect on mGFP-Ca localization as observed 10 min poststimulation in 14 out of 14 cells tested. The scale bars represent 10 mm. (B) Type II PKA holoenzyme diffuses from mitochondria following cAMP stimulation. Cells weakly expressing mGFP-Ca, mCherry-RIa, and DAKAP1a-mCerulean lead to overlap of all three channels under basal conditions. Forskolin/IBMX stimulation led to release of mGFP-Ca from mitochondria, specifically in low-expressing cells in 12 out of 12 cells tested. (C) AKAR2 has no effect on DAKAP1a-localized type I PKA holoenzyme. Cells coexpressing DAKAP1a, RIa, mCherry-Ca (580/20 nm, 600 nm dichroic, 653/95 nm), and AKAR2 were imaged. Untargeted AKAR had no effect on type I PKA separation in 15 out of 15 cells tested. (D) Localized substrate enhances mCherry-Ca release from DAKAP1a localization. Cells coexpressing DAKAP1a, RIa, mCherry-Ca, and DAKAP-AKAR3 were imaged. Targeting the AKAR3 to the surface of mitochondria with a 15 amino acid DAKAP-targeting motif efficiently colocalizes type I PKA holoenzyme and substrate (not shown), and stimulation causes mCherry-Ca release in 18 out of 21 cells tested. The three nondissociated cells have significantly higher expression levels, which led to mitochondrial clumping. (E) Correlated ratiometric detection of PKA activation demonstrates Ca release leads to enhanced kinase activity. We observe less than a 25% increase in the maximal ratio change when comparing AKAR2 to AKAR3. DAKAP1a localization of type I PKA holoenzyme (red trace) inhibits free cytosolic kinase activity (p = 5.9 3 10 À4 ) compared to untethered holoenzyme (black trace). Colocalizing both type I PKA holoenzyme and the reporter to the surface of mitochondria leads to enhanced kinase activation correlated with mCherry-Ca release (green trace). Error bars represent standard error values.
One solution to this paradox may lie in the composition of the AKAP protein complex. Whereas type I PKA holoenzyme is localized by pseudosubstrate tethering, type II PKA is especially sensitive to phosphatase effects. RIIa is known to enhance its affinity to certain AKAPs following S99 phosphorylation [37] , but AKAP-dependent changes in Ca affinity are not known. DAKAP1a scaffolds both PKA and PP1 [38] , suggesting a biologically important interplay, possibly involving suppression of RIIa by PP1-mediated dephosphorylation. AKAP79, an RII-specific AKAP, is colocalized with calcineurin [39] , a phosphatase that can dephosphorylate RII. Therefore, one role of PP1 and calcineurin may be to regulate type II PKA activity directly by controlling dissociation and reassociation. Although in our experiments DAKAP1a-localized RIIa failed to retain Ca following prolonged cAMP elevation, more physiological cAMP stimulation or coexpression of additional phosphatases may lead to a different outcome. Therefore, AKAPs may prevent Ca diffusion by recruiting phosphatases that act to reverse RIIa autophosphorylation, thereby effectively tethering Ca locally. In future experiments, it will be important to observe coaggregation or colocalization to see whether other RII-specific AKAPs release Ca, and whether proteins localized to the AKAP scaffold enhance or inhibit Ca diffusion.
In summary, we have characterized BA-GFP as a genetically encoded, dye-dependent reversible aggregator and demonstrated several applications such as induced colocalization and protein inactivation. By applying this technology to study PKA dissociation, we visualized unique requirements that distinguish PKA holoenzyme subtype activation mechanisms in living cells. Our data strongly suggest substrate-mediated regulation of type I PKA, and regulation by autophosphorylation of type II PKA. BA-GFP is ideal for studying weak interactions that change from nanomolar to micromolar affinity in cells, as fluorescent detection generally requires micromolar levels of overexpression. Furthermore, the temperature-dependent morphologies of BA-GFP aggregation are unique, and may be valuable for understanding the mechanism of many pathologically relevant protein-misfolding diseases.
SIGNIFICANCE
Despite decades of research, visualizing PKA activation in cells has been technically challenging and often misleading. Fluorescently tagged regulatory and catalytic PKA subunits can visualize cAMP responses by FRET as a function of conformational changes. Unfortunately, these techniques do not directly demonstrate separation, and only report a change in the distance and orientation of the two chromophores. Although much has been done in vitro to understand the mechanisms of PKA dissociation, the cellular context of Ca dissociation of each PKA isoform has not been visualized. The tetracysteine sequence YR-ECCPGCCMWR fused to the N terminus of GFP (BA-GFP) causes rapid protein aggregation upon ReAsH labeling in cells. Fusion of this tag to the N terminus of various proteins leads to dye-dependent aggregation as temperature-dependent photo-reversible precipitates. Correlated light and electron microscopy reveal that ReAsH-labeled BA-GFP aggregates are composed of disordered BA-GFP polymers that align into larger fibers at higher labeling temperatures. Using the BA-GFP dye-triggered aggregation system, weak interactions between tagged R and C subunits were trapped in highly visible puncta, providing a simple assay to study the mechanisms of C separation. Type I PKA holoenzyme remains intact following maximal cAMP stimulation, whereas type II PKA rapidly dissociates. Targeting PKA holoenzyme to the outside of mitochondria by coexpression of DAKAP1a confirmed the coaggregation results and demonstrated that type I PKA is only effectively separated by both localized substrate and cAMP stimulation. Overall, type I holoenzyme separation is substrate dependent, whereas type II PKA separation requires autophosphorylation. Additionally, PKA activity can be inhibited by aggregation and restored by biarsenical photobleaching. These observations are central to understanding AKAP-mediated targeting, and point to the presence of phosphatases and substrate local concentration as a mechanism for maintaining localization. Furthermore, a novel approach is introduced for visualizing and manipulating protein interactions by dye-dependent aggregation.
EXPERIMENTAL PROCEDURES
Cell Culture and Biarsenical Labeling HeLa cells were cultured in Dulbecco's modified Eagle's media supplemented with 10% fetal bovine serum, 100 units/ml penicillin G, and 100 mg/ml streptomycin. Cells were transfected using Fugene HD (Roche) 2 days prior to imaging, and starved in serum-free media overnight. Biarsenical labeling was performed with 1.0 mM ReAsH or 2.5 mM CHoXAsH with 10 mM ethanedithiol (EDT) in Hanks balanced saline solution supplemented with 2 g/l glucose and 20 mM HEPES for 60 min at room temperature or in serum-free media at 37 C. Cyclic AMP was elevated by addition of 10 mM forskolin (Sigma) and 100 mM IBMX (Sigma) simultaneous with biarsenical addition. Using purified recombinant standards for normalization by western blot, HeLa cells express endogenous RIa and RIIa at relatively equal levels. Biarsenical-stained cells were washed with 0.25 mM 2,3-dimercaptopropanol (BAL) to remove nonspecific ReAsH staining. BA-GFP protein was purified from overexpressing HEK293 cells and labeled in vitro as previously described [13] . 
Correlated Light and Electron Microscopy
ReAsH-labeled cells were fixed in 2% glutaraldehyde in sodium cacodylate buffer (0.1 M, pH 7.4) at 4 C for 20 min. Cells were then rinsed in cacodylate buffer and treated for 5 min with blocking buffer: 10 mM KCN, 10 mM aminotriazole, 0.01% hydrogen peroxide, 50 mM glycine in 0.1 M cacodylate buffer. Images of cells were recorded using a BioRad MRC-1024 confocal system on a Zeiss Axiovert 35M microscope using 568 nm laser excitation and a 633 1.4 NA objective. The buffer was replaced with oxygenated buffer containing 1 mg/ml DAB, and photoconversion was performed by using intense illumination (75 W xenon lamp without neutral density filters) focused through the microscope objective using a standard rhodamine filter set (535/50 nm, 580 nm dichroic, 590 nm long pass). After a brownish reaction product replaced the fluorescence (8-10 min), the cells were rinsed in cacodylate buffer and postfixed in 2% osmium tetroxide for 1 hr at 4 C. The cells were then dehydrated in ethanol and infiltrated in Durcupan ACM resin (Electron Microscopy Sciences) and polymerized at 60 C.
Ultrathin sections were prepared and imaged using a JEOL 1200 electron microscope at 80 kev.
PKA Activity Measurements
Serum-starved HeLa cells expressing AKAR2, AKAR2-NLS, or DA-KAP-AKAR3 (420/20 nm, 450 nm dichroic, CFP: 475/40 nm and YFP: 535/25 nm) were imaged every 3 min (unless otherwise noted) and stimulated with 25 mM forskolin and 100 mM IBMX. Twelve or more regions from a single dish were imaged in parallel using a computer-controlled stage. Cells with similar medium levels of AKAR2 or AKAR2-NLS expression were analyzed for each condition and ratios were calculated by dividing background-subtracted YFP-FRET by CFP emission and normalized to basal starting ratio.
Supplemental Data
Supplemental Data include five figures, one table, Supplemental Experimental Procedures, and two movies, and are available at http:// www.chembiol.com/cgi/content/full/14/9/1031/DC1/.
